keyword
https://read.qxmd.com/read/38642003/a-case-of-excisionally-remitted-indolent-nk-cell-enteropathy-in-the-oral-cavity-and-a-mini-review
#21
Xiangyun Li, Zhu Li, Xiaoge Zhou, Yuanyuan Zheng, Yanlin Zhang, Jianlan Xie
Benign natural killer cell enteropathy (NKCE) was first identified in the gastrointestinal (GI) tract. Notably, instances of NKCE have previously been observed at various sites other than the GI tract, including the gallbladder, lymph nodes, esophagus, and female genital tract. Typical NKCE manifests as an NK-cell immunohistological phenotype, with or without TCR rearrangement, and is characterized by the absence of Epstein-Barr virus (EBV) infection and protracted clinical progression. The misdiagnosis of NKT-cell lymphoma has resulted in some patients receiving chemotherapy, while in other instances, the patients' conditions resolved without treatment and showed no evidence of disease recurrence or progression during follow-up examinations...
April 20, 2024: Journal of Cutaneous Pathology
https://read.qxmd.com/read/38641806/biochemical-morphological-and-molecular-assessments-of-n-butanol-fraction-of-phoenix-dactylifera-l-following-exposure-to-inorganic-mercury-on-the-liver-of-wistar-rats
#22
JOURNAL ARTICLE
Musa Garba Abubakar, A N Agbon, S A Musa, W O Hamman, S B Oladele
BACKGROUND: Mercury chloride (HgCl2 ) damages tissues it comes in contact with in sufficient concentration. This study evaluated the protective effects of n-butanol fraction of Phoenix dactylifera (BFPD) on mercury-triggered liver toxicity in Wistar rats. 25 male rats were divided into 5 groups of 5 rats each. Group I was administered 2 ml/kg of distilled water; group II was administered 5 mg/kg of HgCl2 ; group III was administered 500 mg/kg of BFPD + 5 mg/kg of HgCl2 ; group IV was administered 1000 mg/kg of BFPD + 5 mg/kg of HgCl2 , while group V was administered 100 mg/kg of silymarin + 5 mg/kg of HgCl2 ...
April 19, 2024: Laboratory Animal Research
https://read.qxmd.com/read/38641628/nonbacterial-thrombotic-endocarditis-of-mitral-valve-associated-with-a-lymphoproliferative-malignancy-case-report-and-literature-review
#23
JOURNAL ARTICLE
Fabiana Duarte, Maria Inês Barradas, Ana Raquel Dias, Carlos Faria, Carina Machado, Carolina Pavão
BACKGROUND: Non-bacterial thrombotic endocarditis (NBTE) is a rare condition marked by sterile vegetations on cardiac valves, often linked to rheumatologic diseases, autoimmune disorders, and advanced solid malignancies. An early diagnosis and treatment of the associated clinical condition are mandatory, although they do not usually eliminate valvular vegetations, making anticoagulation essential to prevent embolic events. Despite variability, the prognosis of NBTE is usually unfavorable due to recurrent embolic events and the severity of the primary condition, typically advanced cancer...
April 19, 2024: Cardio-Oncology
https://read.qxmd.com/read/38641486/soho-state-of-the-art-updates-and-next-questions-diagnosis-and-management-of-monoclonal-gammopathy-of-undetermined-significance-and-smoldering-multiple-myeloma
#24
REVIEW
Timothy Schmidt, Zhubin Gahvari, Natalie S Callander
Monoclonal proteins are common, with a prevalence in the United States around 5% and the incidence increases with age. Although most patients are asymptomatic, the vast majority of cases are caused by a clonal plasma cell disorder. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic precursor conditions with variable risk of progression to multiple myeloma (MM). In recent years, significant progress has been made to better understand the factors that lead to the development of symptoms and progression to myeloma...
March 16, 2024: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/38641485/mantle-cell-lymphoma-under-the-scope-of-personalized-medicine-perspective-and-directions
#25
REVIEW
Lara Gallucci Figorelle, Peterson Tiago Galvão, Felipe Matheus Ribeiro de Lima, Patricia Marimon, Nathalia Pentagna, Cristiane Milito, Rony Schaffel, Katia Carneiro
Mantle cell lymphoma (MCL) is a rare, incurable non-Hodgkin's lymphoma characterized by naive B cells infiltrating the lymphoid follicle's mantle zone. A key feature of MCL is the cytogenetic abnormality t(11;14) (q13:q14), found in 95% of cases, leading to Cyclin D1 overexpression resulting in uncontrolled cell cycle progression and genetic instability. Occasionally, Cyclin D2 or D3 overexpression can substitute for Cyclin D1, causing similar effects. The transcription factor SOX11 is a hallmark of classical Cyclin D1-positive MCL and also in cases without the typical t(11;14) abnormality, making it an important diagnostic marker...
March 27, 2024: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/38641241/bruton-s-tyrosine-kinase-inhibitors-in-refractory-or-relapsing-primary-central-nervous-system-lymphoma-a-meta-analysis-and-systematic-review
#26
REVIEW
Huai-Peng Guo, Xue-Liang Dang, Lei Kang, Cong Liu, Xiao-Wu Liu
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is an aggressive lymphoma that primarily affects the central nervous system. Current treatments, such as surgery, chemotherapy, and whole-brain radiotherapy, often fail to achieve satisfactory results. The prognosis for patients with refractory or relapsed (R/R) PCNSL is bleak. The optimal treatment for refractory or relapsed PCNSL is poorly defined due to a limited number of studies in this setting. Bruton's tyrosine kinase (BTK) inhibitors, as part of targeted therapy regimens, have undergone testing in several clinical trials against PCNSL and have shown promising results in the treatment of R/R PCNSL...
April 17, 2024: World Neurosurgery
https://read.qxmd.com/read/38641058/cost-effectiveness-of-axicabtagene-ciloleucel-for-adult-patients-with-relapsed-or-refractory-follicular-lymphoma-in-the-united-states
#27
JOURNAL ARTICLE
Olalekan O Oluwole, Markqayne D Ray, Katherine L Rosettie, Graeme Ball, Jorge Jacob, S Pinar Bilir, Anik R Patel, Caron A Jacobson
OBJECTIVES: The results of a recent single-arm trial (ZUMA-5) of axicabtagene ciloleucel (axi-cel) for relapsed/refractory (r/r) FL demonstrated high rates of durable response and tolerable toxicity among treated patients. To quantify the value of axi-cel compared to standard of care (SOC) to manage r/r FL patients who have had at least two prior lines of systemic therapy (3L+), a cost-effectiveness model was developed from a US third-party payer perspective. METHODS: A three-state partitioned survival cost-effectiveness model was developed with a lifetime horizon...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38640784/implantable-car-t-cell-factories-enhance-solid-tumor-treatment
#28
JOURNAL ARTICLE
Sharda Pandit, Pritha Agarwalla, Feifei Song, Anton Jansson, Gianpietro Dotti, Yevgeny Brudno
Chimeric Antigen Receptor (CAR) T cell therapy has produced revolutionary success in hematological cancers such as leukemia and lymphoma. Nonetheless, its translation to solid tumors faces challenges due to manufacturing complexities, short-lived in vivo persistence, and transient therapeutic impact. We introduce 'Drydux' - an innovative macroporous biomaterial scaffold designed for rapid, efficient in-situ generation of tumor-specific CAR T cells. Drydux expedites CAR T cell preparation with a mere three-day turnaround from patient blood collection, presenting a cost-effective, streamlined alternative to conventional methodologies...
April 15, 2024: Biomaterials
https://read.qxmd.com/read/38640588/discovery-of-novel-pyridone-benzamide-derivatives-possessing-a-1-methyl-2-benzimidazolinone-moiety-as-potent-ezh2-inhibitors-for-the-treatment-of-b-cell-lymphomas
#29
JOURNAL ARTICLE
Di Wu, Xiaoyi Zeng, Yuanhao Zhao, Mingze Qin, Ping Gong
Enhancer of zeste homolog 2 (EZH2) is a promising therapeutic target for diffuse large B-cell lymphoma. In this study, based on the binding model of 1 (tazemetostat) with polycomb repressive complex 2 (PRC2), we designed and synthesized a series of tazemetostat analogs bearing a 1-methyl-2-benzimidazolinone moiety to improve the inhibitory activity of EZH2 wild-type (WT) and Y641 mutants and enhance metabolic stability. After the assessment of the structure-activity relationship at enzymatic and cellular levels, compound N40 was identified...
April 14, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38640287/breast-mucosa-associated-lymphoid-tissue-lymphoma-a-case-report-and-literature-review
#30
JOURNAL ARTICLE
Siyi Luo, Xinyue Zhang, Zhichun Wang
BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphoma, also known as extranodal marginal zone lymphoma, is more commonly detected in the stomach and rarely in the breast. Our study presented a clinical and pathological examination of a patient diagnosed with breast MALT lymphoma, supplemented with pertinent research, to offer guidance for the diagnosis and treatment of this condition. PEOPLE CONCERNS: The occurrence of breast MALT lymphoma has risen in the past decade, but its etiology, progression and treatment response are less well-studied...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38640255/co-targeting-ebv-lytic-as-well-as-latent-cycle-antigens-increases-t-cell-potency-against-lymphoma
#31
JOURNAL ARTICLE
Sandhya Sharma, Naren U Mehta, Tim Sauer, Dirk P Dittmer, Lisa A Rollins, Cliona M Rooney
The remarkable efficacy of Epstein-Barr virus (EBV) specific T-cells for the treatment of post-transplant lymphomas (PTLD) has not been reproduced for EBV+ malignancies outside the transplant setting. This is due in part to the heterogeneous expression and poor immunogenicity of the viral antigens expressed, namely LMPs 1 and 2, EBNA1, and BARF1 (type-2 (T2) latency). However, EBV lytic cycle proteins are also expressed in certain EBV+ malignancies, and since several EBV lytic cycle proteins are abundantly expressed, have oncogenic activity, and likely contribute to malignancy, we sought and identified viral lytic-cycle transcripts in EBV+ Hodgkin's lymphoma biopsies...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38639715/impact-of-carbimazole-combined-with-vitamin-e-on-testicular-injury-induced-by-experimental-hyperthyroidism-in-adult-albino-rats-oxidative-inflammatory-apoptotic-pathways
#32
JOURNAL ARTICLE
Ramadan S Hussein, Moustafa M Eyada, Rashad M Mostafa, Samah M Elaidy, Shereen H Elsayed, Hany M Saad
Thyroid hormones play essential roles in spermatogenesis, but their effects on infertile males remain poorly understood. This study aimed to evaluate the impact of combining carbimazole (CBZ) with vitamin E (VE) on testicular injury induced by experimental hyperthyroidism in adult albino rats, focusing on oxidative, inflammatory, and apoptotic pathways. In this experimental study, 64 adult male albino Wistar rats were divided into eight groups: Group I (control-untreated), Group II (CBZ-control), Group III (VE-control), Group IV (CBZ + VE-control), Group V (levothyroxine-induced testicular injury), Group VI (levothyroxine + CBZ-treated), Group VII (levothyroxine + VE-treated), and Group VIII (levothyroxine + CBZ + VE-treated)...
April 19, 2024: Asian Journal of Andrology
https://read.qxmd.com/read/38639192/efficacy-of-ruxolitinib-in-the-treatment-of-relapsed-refractory-large-granular-lymphocytic-leukaemia
#33
JOURNAL ARTICLE
Tony Marchand, Cédric Pastoret, Gandhi Damaj, Angélique Lebouvier, Charles Herbaux, Aline Moignet, Miguel Pavlosky, Astrid Pavlosky, Anaise Blouet, Martin Eloit, Vincent Launay, Pierre Lebreton, Aspasia Stamatoullas, Christer Nilsson, Marlène Ochmann, Juliette Prola, Thierry Lamy
Large granular lymphocytic (LGL) leukaemia is a rare chronic lymphoproliferative disorder characterized by an expansion of cytotoxic T or NK cells. Despite a usually indolent evolution, most patients will require a treatment over the course of the disease because of cytopenia or symptomatic associated autoimmune disorders. First-line treatment is based on immunosuppressive agents, namely cyclophosphamide, methotrexate and ciclosporin. However, relapses are frequent, and there is no consensus on the management of relapsed/refractory patients...
April 19, 2024: British Journal of Haematology
https://read.qxmd.com/read/38639124/-blitz-af-cancer-study-an-international-observational-research-project-on-patients-with-atrial-fibrillation-and-cancer
#34
JOURNAL ARTICLE
Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, Marco Alings, Ronan Collins, Leonardo De Luca, Marcello Di Nisio, Donata Lucci, Domenico Gabrielli, Stefan Janssens, Iris Parrini, Fausto J Pinto, Jose Luis Zamorano, Furio Colivicchi
BACKGROUND: Cancer is an important condition associated with the development of atrial fibrillation (AF). The objectives of the BLITZ-AF Cancer study were to collect real-life information on the clinical profile and use of antithrombotic drugs in patients with AF and cancer to improve clinical management, as well as the evaluation of the association between different antithrombotic treatments (or their absence) and the main clinical events. METHODS: European multinational, multicenter, prospective, non-interventional study conducted in patients with AF (electrocardiographically confirmed) and cancer occurring within 3 years...
May 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38638728/first-use-of-upfront-polatuzumab-vedotin-in-post-transplant-lymphoproliferative-disorder-a-case-report
#35
Sreshta Paranji, Amir Steinberg
Post-transplant lymphoproliferative disorder (PTLD) is a condition that is highly variable in presentation but life-threatening for post-transplant, immunosuppressed patients. Current standard management in PTLD sees the use of a chemoimmunotherapy regimen similar to the management of diffuse large B-cell lymphoma. Here, we discuss the case of a 33-year-old male with a history of renal transplant, hemodynamically stable, who presented with fevers and night sweats lasting one month. Investigations revealed multiple masses in his liver, the largest of which was biopsied and revealed diffuse large B-cell lymphoma...
March 2024: Curēus
https://read.qxmd.com/read/38638442/advancements-in-cancer-immunotherapies-targeting-cd20-from-pioneering-monoclonal-antibodies-to-chimeric-antigen-receptor-modified-t-cells
#36
REVIEW
Agnieszka Dabkowska, Krzysztof Domka, Malgorzata Firczuk
CD20 located predominantly on the B cells plays a crucial role in their development, differentiation, and activation, and serves as a key therapeutic target for the treatment of B-cell malignancies. The breakthrough of monoclonal antibodies directed against CD20, notably exemplified by rituximab, revolutionized the prognosis of B-cell malignancies. Rituximab, approved across various hematological malignancies, marked a paradigm shift in cancer treatment. In the current landscape, immunotherapies targeting CD20 continue to evolve rapidly...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638435/arginine-alleviates-clostridium-perfringens-%C3%AE-toxin-induced-intestinal-injury-in-vivo-and-in-vitro-via-the-slc38a9-mtorc1-pathway
#37
JOURNAL ARTICLE
Xiaohui Wang, Tong Zhang, Wenli Li, Heliang Wang, Lei Yan, Xiaowen Zhang, Lianwen Zhao, Nianxue Wang, Beibei Zhang
INTRODUCTION: Clostridium perfringens α toxin is a main virulence factor responsible for gut damage in animals. Arginine is a functional amino acid exhibiting significant immunoregulatory activities. However, the effects and immunoregulatory mechanisms of arginine supplementation on α toxin-induced intestinal injury remain unclear. METHODS: In vivo , 256 male Arbor Acres chickens were randomly assigned to a 2×2 factorial arrangement, involving diet treatments (with or without 0...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638256/guiding-function-of-positron-emission-tomography-computed-tomography-examination-in-the-diagnosis-and-treatment-of-ocular-adnexal-mucosa-associated-lymphoid-tissue-lymphoma
#38
JOURNAL ARTICLE
Xuan Zhang, Qi-Han Guo, Rui Liu, Jing Li, Ying-Chao Li, Jian-Min Ma
AIM: To explore the role of positron emission tomography-computed tomography (PET-CT) examination in the diagnosis and treatment of ocular adnexal mucosa associated lymphoid tissue lymphoma (OAML). METHODS: The general clinical data, postoperative PET-CT results, treatment regimens, and the prognosis of 21 histopathologically confirmed OAML patients between October 2017 and September 2021 were collected. Among the 21 patients, five patients underwent surgical treatment alone, 13 patients underwent surgical treatment combined with radiotherapy, and three patients underwent surgical treatment combined with chemotherapy...
2024: International Journal of Ophthalmology
https://read.qxmd.com/read/38638038/astaxanthin-as-an-anticancer-agent-against-breast-cancer-an-in-vivo-and-in-vitro-investigation
#39
JOURNAL ARTICLE
Maryam Shokrian Zeini, Seyyed Mohammad Pakravesh, Seyed Mostafa Jalili Kolour, Shahrad Soghala, Mohammad Amin Dabbagh Ohadi, Haniyeh Ghanbar Ali Akhavan, Zeinab Sayyahi, Lena Mahya, Saleheh Jahani, Sadegh Shojaei Baghini, Tahereh Farkhondeh, Mahboubeh Kabiri, Saeed Samarghandian
AIM: This study aimed to investigate the antioxidant properties, cytotoxic activity, and apoptotic effects of astaxanthin (ASX) on genes and pathways involved in breast cancer in Balb/c mice models injected with the 4T1 cell line. BACKGROUND: ASX could inhibit some tumor progression by using in vivo and in vitro models. OBJECTIVE: The effect of ASX on breast cancer was not fully understood till now. METHOD: In an in vivo model, 4T1 cells-injected mice were administered with different concentrations of ASX (100 and 200 mg/kg), and histopathological evaluations were done using an optical microscope and the hematoxylin and eosin (H&E) staining...
April 17, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38637781/primary-cutaneous-anaplastic-large-cell-lymphoma-resembling-infratemporal-space-infection-a-case-report
#40
JOURNAL ARTICLE
Xiaohan Yan, Wenhao Ren, Shaoming Li, Zhuang Zhu, Ling Gao, Keqian Zhi
BACKGROUND: Primary cutaneous anaplastic large-cell lymphoma (PC-ALCL) is a rare T-cell lymphoma belonging to the CD30 + T-cell lymphoproliferative disorders. The case of PC-ALCL in the temporal region is exceedingly rare. Herein, we report a case of PC-ALCL involving the temporal region mimicking infratemporal space infection. CASE PRESENTATION: A 78-year-old woman presented to maxillofacial surgery service with a 6-month history of swelling and pain in the left side of her face...
April 18, 2024: BMC Oral Health
keyword
keyword
4098
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.